Deaths from cancer reflect global inequity, and the burden of disease is concentrated in low- and middle-income countries. Due to high costs of treatment, resource-constrained governments are unlikely to treat their way out of cancer in their populations. Though prevention lacks the social visibility and market appeal of treatment, 30% to 50% of cancers are preventable. This issue is devoted to exploring the ethical complexities of cancer prevention as a global public health imperative.